• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CT 扫描和全切片图像的放射组学模型的开发和验证,用于区分Ⅰ-Ⅱ期和Ⅲ期胃癌。

Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.

机构信息

Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

出版信息

BMC Cancer. 2024 Mar 22;24(1):368. doi: 10.1186/s12885-024-12021-2.

DOI:10.1186/s12885-024-12021-2
PMID:38519974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10960497/
Abstract

OBJECTIVE

This study aimed to develop and validate an artificial intelligence radiopathological model using preoperative CT scans and postoperative hematoxylin and eosin (HE) stained slides to predict the pathological staging of gastric cancer (stage I-II and stage III).

METHODS

This study included a total of 202 gastric cancer patients with confirmed pathological staging (training cohort: n = 141; validation cohort: n = 61). Pathological histological features were extracted from HE slides, and pathological models were constructed using logistic regression (LR), support vector machine (SVM), and NaiveBayes. The optimal pathological model was selected through receiver operating characteristic (ROC) curve analysis. Machine learnin algorithms were employed to construct radiomic models and radiopathological models using the optimal pathological model. Model performance was evaluated using ROC curve analysis, and clinical utility was estimated using decision curve analysis (DCA).

RESULTS

A total of 311 pathological histological features were extracted from the HE images, including 101 Term Frequency-Inverse Document Frequency (TF-IDF) features and 210 deep learning features. A pathological model was constructed using 19 selected pathological features through dimension reduction, with the SVM model demonstrating superior predictive performance (AUC, training cohort: 0.949; validation cohort: 0.777). Radiomic features were constructed using 6 selected features from 1834 radiomic features extracted from CT scans via SVM machine algorithm. Simultaneously, a radiopathomics model was built using 17 non-zero coefficient features obtained through dimension reduction from a total of 2145 features (combining both radiomics and pathomics features). The best discriminative ability was observed in the SVM_radiopathomics model (AUC, training cohort: 0.953; validation cohort: 0.851), and clinical decision curve analysis (DCA) demonstrated excellent clinical utility.

CONCLUSION

The radiopathomics model, combining pathological and radiomic features, exhibited superior performance in distinguishing between stage I-II and stage III gastric cancer. This study is based on the prediction of pathological staging using pathological tissue slides from surgical specimens after gastric cancer curative surgery and preoperative CT images, highlighting the feasibility of conducting research on pathological staging using pathological slides and CT images.

摘要

目的

本研究旨在开发和验证一种人工智能放射病理模型,该模型使用术前 CT 扫描和术后苏木精和伊红(HE)染色切片来预测胃癌的病理分期(I-II 期和 III 期)。

方法

本研究共纳入 202 例经病理分期证实的胃癌患者(训练队列:n=141;验证队列:n=61)。从 HE 切片中提取病理组织学特征,并使用逻辑回归(LR)、支持向量机(SVM)和朴素贝叶斯构建病理模型。通过接收者操作特征(ROC)曲线分析选择最佳病理模型。使用最佳病理模型,通过机器学习算法构建放射组学模型和放射病理模型。使用 ROC 曲线分析评估模型性能,并使用决策曲线分析(DCA)估计临床实用性。

结果

从 HE 图像中提取了 311 个病理组织学特征,包括 101 个术语频率逆文档频率(TF-IDF)特征和 210 个深度学习特征。通过降维,使用 19 个选定的病理特征构建了一个病理模型,其中 SVM 模型表现出较好的预测性能(AUC,训练队列:0.949;验证队列:0.777)。使用 SVM 机器算法从 1834 个从 CT 扫描中提取的放射组学特征中构建了放射组学特征。同时,通过降维从总共 2145 个特征(结合放射组学和病理组学特征)中构建了一个放射病理模型。SVM_radiopathomics 模型具有最佳的判别能力(AUC,训练队列:0.953;验证队列:0.851),且临床决策曲线分析(DCA)显示出优异的临床实用性。

结论

放射病理组学模型结合了病理和放射组学特征,在区分 I-II 期和 III 期胃癌方面表现出较好的性能。本研究基于对胃癌根治术后手术标本的病理组织切片和术前 CT 图像进行病理分期预测,突出了使用病理切片和 CT 图像进行病理分期研究的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/d816996138bf/12885_2024_12021_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/fea9c7310bec/12885_2024_12021_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/b7413f1cee5e/12885_2024_12021_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/d713ed9eee20/12885_2024_12021_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/a6cd0134f861/12885_2024_12021_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/66c0da3e93bd/12885_2024_12021_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/7c05b64fa6e3/12885_2024_12021_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/d816996138bf/12885_2024_12021_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/fea9c7310bec/12885_2024_12021_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/b7413f1cee5e/12885_2024_12021_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/d713ed9eee20/12885_2024_12021_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/a6cd0134f861/12885_2024_12021_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/66c0da3e93bd/12885_2024_12021_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/7c05b64fa6e3/12885_2024_12021_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f15/10960497/d816996138bf/12885_2024_12021_Fig7_HTML.jpg

相似文献

1
Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.基于 CT 扫描和全切片图像的放射组学模型的开发和验证,用于区分Ⅰ-Ⅱ期和Ⅲ期胃癌。
BMC Cancer. 2024 Mar 22;24(1):368. doi: 10.1186/s12885-024-12021-2.
2
A comprehensive radiopathological nomogram for the prediction of pathological staging in gastric cancer using CT-derived and WSI-based features.一种利用CT衍生特征和基于全切片图像(WSI)的特征预测胃癌病理分期的综合放射病理学列线图。
Transl Oncol. 2024 Feb;40:101864. doi: 10.1016/j.tranon.2023.101864. Epub 2023 Dec 22.
3
Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.构建和验证人工智能病理组学模型以预测结直肠癌的病理分期:使用多模态数据和临床变量。
Cancer Med. 2024 Apr;13(7):e6947. doi: 10.1002/cam4.6947.
4
An Integrated Radiopathomics Machine Learning Model to Predict Pathological Response to Preoperative Chemotherapy in Gastric Cancer.一种用于预测胃癌术前化疗病理反应的综合放射组学机器学习模型。
Acad Radiol. 2025 Jan;32(1):134-145. doi: 10.1016/j.acra.2024.08.014. Epub 2024 Aug 30.
5
Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.开发和验证一种放射组学模型,以预测局部晚期直肠癌新辅助放化疗的病理完全缓解:一项多中心观察性研究。
Lancet Digit Health. 2022 Jan;4(1):e8-e17. doi: 10.1016/S2589-7500(21)00215-6.
6
An Integrated Clinical and Computerized Tomography-Based Radiomic Feature Model to Separate Benign from Malignant Pleural Effusion.基于临床与计算机断层扫描的放射组学特征模型,用于区分良性和恶性胸腔积液。
Respiration. 2024;103(7):406-416. doi: 10.1159/000536517. Epub 2024 Feb 29.
7
The predictive potential of contrast-enhanced computed tomography based radiomics in the preoperative staging of cT4 gastric cancer.基于对比增强计算机断层扫描的影像组学在cT4期胃癌术前分期中的预测潜力。
Quant Imaging Med Surg. 2022 Nov;12(11):5222-5238. doi: 10.21037/qims-22-286.
8
Comparative assessment of the capability of machine learning-based radiomic models for predicting omental metastasis in locally advanced gastric cancer.基于机器学习的放射组学模型预测局部进展期胃癌网膜转移能力的比较评估。
Sci Rep. 2024 Jul 13;14(1):16208. doi: 10.1038/s41598-024-66979-x.
9
Machine learning models combining computed tomography semantic features and selected clinical variables for accurate prediction of the pathological grade of bladder cancer.结合计算机断层扫描语义特征和选定临床变量的机器学习模型,用于准确预测膀胱癌的病理分级。
Front Oncol. 2023 May 8;13:1166245. doi: 10.3389/fonc.2023.1166245. eCollection 2023.
10
Multiparametric MRI-based radiomics combined with pathomics features for prediction of the efficacy of neoadjuvant chemotherapy in breast cancer.基于多参数磁共振成像的影像组学联合病理组学特征预测乳腺癌新辅助化疗疗效
Heliyon. 2024 Jan 12;10(2):e24371. doi: 10.1016/j.heliyon.2024.e24371. eCollection 2024 Jan 30.

引用本文的文献

1
Construction of an oligometastatic prediction model for nasopharyngeal carcinoma patients based on pathomics features and dynamic multi-swarm particle swarm optimization support vector machine.基于病理组学特征和动态多群粒子群优化支持向量机构建鼻咽癌寡转移预测模型
Front Oncol. 2025 Jun 19;15:1589919. doi: 10.3389/fonc.2025.1589919. eCollection 2025.
2
Pathomics in Gastrointestinal Tumors: Research Progress and Clinical Applications.胃肠道肿瘤的病理组学:研究进展与临床应用
Cureus. 2025 May 29;17(5):e85060. doi: 10.7759/cureus.85060. eCollection 2025 May.
3
Advances in the use of Radiomics and Pathomics for predicting the efficacy of neoadjuvant therapy in tumors.

本文引用的文献

1
Multi-modal analysis for accurate prediction of preoperative stage and indications of optimal treatment in gastric cancer.多模态分析用于准确预测胃癌术前分期及最佳治疗指征
Radiol Med. 2023 May;128(5):509-519. doi: 10.1007/s11547-023-01625-6. Epub 2023 Apr 28.
2
Relationship between the deep features of the full-scan pathological map of mucinous gastric carcinoma and related genes based on deep learning.基于深度学习的黏液性胃癌全扫描病理图像深度特征与相关基因的关系
Heliyon. 2023 Mar 9;9(3):e14374. doi: 10.1016/j.heliyon.2023.e14374. eCollection 2023 Mar.
3
Gastric adenocarcinoma: A review of the TNM classification system and ways of spreading.
放射组学和病理组学在预测肿瘤新辅助治疗疗效方面的应用进展。
Transl Oncol. 2025 Aug;58:102435. doi: 10.1016/j.tranon.2025.102435. Epub 2025 May 30.
4
Beyond Biomarkers: Machine Learning-Driven Multiomics for Personalized Medicine in Gastric Cancer.超越生物标志物:机器学习驱动的多组学在胃癌个性化医疗中的应用
J Pers Med. 2025 Apr 24;15(5):166. doi: 10.3390/jpm15050166.
5
An interpretable framework for gastric cancer classification using multi-channel attention mechanisms and transfer learning approach on histopathology images.一种基于多通道注意力机制和迁移学习方法的胃癌组织病理学图像分类可解释框架。
Sci Rep. 2025 Apr 16;15(1):13087. doi: 10.1038/s41598-025-97256-0.
6
CCL26 as a prognostic biomarker in hepatocellular carcinoma: integrating bioinformatics analysis, clinical validation, and radiomics score.CCL26作为肝细胞癌的预后生物标志物:整合生物信息学分析、临床验证和影像组学评分
Discov Oncol. 2025 Apr 9;16(1):502. doi: 10.1007/s12672-025-02280-1.
7
The artificial intelligence revolution in gastric cancer management: clinical applications.胃癌管理中的人工智能革命:临床应用
Cancer Cell Int. 2025 Mar 21;25(1):111. doi: 10.1186/s12935-025-03756-4.
8
The data scientist as a mainstay of the tumor board: global implications and opportunities for the global south.作为肿瘤多学科会诊核心成员的数据科学家:全球影响及全球南方地区的机遇
Front Digit Health. 2025 Feb 6;7:1535018. doi: 10.3389/fdgth.2025.1535018. eCollection 2025.
9
Deep learning and radiomics for gastric cancer serosal invasion: automated segmentation and multi-machine learning from two centers.深度学习与影像组学在胃癌浆膜侵犯中的应用:来自两个中心的自动分割与多机器学习
J Cancer Res Clin Oncol. 2025 Feb 3;151(2):60. doi: 10.1007/s00432-025-06117-w.
10
Correction: Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.更正:基于CT扫描和全切片图像的放射组学模型的开发与验证,用于鉴别I-II期和III期胃癌。
BMC Cancer. 2024 Apr 15;24(1):469. doi: 10.1186/s12885-024-12240-7.
胃腺癌:TNM 分类系统和扩散方式综述。
Radiologia (Engl Ed). 2023 Jan-Feb;65(1):66-80. doi: 10.1016/j.rxeng.2022.10.011.
4
A novel pathomics signature for gastric cancer.一种用于胃癌的新型病理组学特征。
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):3. doi: 10.1038/s41575-022-00719-2.
5
Prognostic and predictive value of a pathomics signature in gastric cancer.胃癌中病理组学特征的预后和预测价值。
Nat Commun. 2022 Nov 12;13(1):6903. doi: 10.1038/s41467-022-34703-w.
6
Radiomics in precision medicine for gastric cancer: opportunities and challenges.精准医学中的胃癌放射组学:机遇与挑战。
Eur Radiol. 2022 Sep;32(9):5852-5868. doi: 10.1007/s00330-022-08704-8. Epub 2022 Mar 22.
7
Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.选择新辅助放化疗后保留器官策略的候选者:整合 MRI 放射组学和病理组学的模型的开发和验证。
J Magn Reson Imaging. 2022 Oct;56(4):1130-1142. doi: 10.1002/jmri.28108. Epub 2022 Feb 10.
8
Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients.开发一种新型的联合列线图模型,整合深度学习病理组学、放射组学和免疫评分,以预测结直肠癌肺转移患者的术后结局。
J Hematol Oncol. 2022 Jan 24;15(1):11. doi: 10.1186/s13045-022-01225-3.
9
Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.开发和验证一种放射组学模型,以预测局部晚期直肠癌新辅助放化疗的病理完全缓解:一项多中心观察性研究。
Lancet Digit Health. 2022 Jan;4(1):e8-e17. doi: 10.1016/S2589-7500(21)00215-6.
10
Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer.肿瘤比例转移分期系统与第八版美国癌症联合委员会(AJCC)胃癌TNM分期系统的比较
Front Oncol. 2021 Jul 8;11:595421. doi: 10.3389/fonc.2021.595421. eCollection 2021.